Should everyone with an ejection fraction less than or equal to 30% receive an implantable cardioverter-defibrillator? Everyone with an ejection fraction less than or equal to 30% should receive an implantable cardioverter-defibrillator - Response

被引：0
|
作者：
Buxton, AE
机构：
来源：
CIRCULATION | 2005年 / 111卷 / 19期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2548 / 2548
页数：1
相关论文
共 50 条
  • [21] Successful use of a wearable cardioverter-defibrillator in myocarditis with normal ejection fraction
    Prochnau, Dirk
    Surber, Ralf
    Kuehnert, Helmut
    Heinke, Matthias
    Klein, Helmut U.
    Figulla, Hans R.
    CLINICAL RESEARCH IN CARDIOLOGY, 2010, 99 (02) : 129 - 131
  • [22] Successful use of a wearable cardioverter-defibrillator in myocarditis with normal ejection fraction
    Dirk Prochnau
    Ralf Surber
    Helmut Kuehnert
    Matthias Heinke
    Helmut U. Klein
    Hans R. Figulla
    Clinical Research in Cardiology, 2010, 99 : 129 - 131
  • [23] Effect of Coronary Artery Bypass Grafting on Left Ventricular Ejection Fraction in Men Eligible for Implantable Cardioverter-Defibrillator
    Vakil, Kairav
    Florea, Viorel
    Koene, Ryan
    Kealhofer, Jessica Voight
    Anand, Inderjit
    Adabag, Selcuk
    AMERICAN JOURNAL OF CARDIOLOGY, 2016, 117 (06): : 957 - 960
  • [24] Evolution of Left Ventricular Ejection Fraction After Acute Myocardial Infarction Implications for Implantable Cardioverter-Defibrillator Eligibility
    Sjoblom, Johanna
    Muhrbeck, Josephine
    Witt, Nils
    Alam, Mahbubul
    Frykman-Kull, Viveka
    CIRCULATION, 2014, 130 (09) : 743 - 748
  • [25] Assessment of Implantable Cardioverter-Defibrillator Used in Heart Failure with Reduced Ejection Fraction as Primary Prevention in an Underserved Population
    Lu, Yifan
    Wan, Ningxin
    Madan, Nidhi
    Hovnanians, Ninel
    Diaz, Juan Carlos Ruiz
    Christia, Panagiota
    Faillace, Robert
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2018, 33 (11) : 1854 - 1856
  • [26] Implantable Cardioverter-Defibrillator Use Among Medicare Patients With Low Ejection Fraction After Acute Myocardial Infarction
    Pokorney, Sean D.
    Miller, Amy L.
    Chen, Anita Y.
    Thomas, Laine
    Fonarow, Gregg C.
    de Lemos, James A.
    Al-Khatib, Sana M.
    Peterson, Eric D.
    Wang, Tracy Y.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2015, 313 (24): : 2433 - 2440
  • [27] Racial differences in implantable cardioverter-defibrillator utilization among patients with prior myocardial infariction and an ejection fraction ≤ 35%
    Thomas, K
    Al-Khatib, S
    Kelsey, R
    Brosius, L
    Gilliam, F
    CIRCULATION, 2005, 112 (17) : U883 - U883
  • [28] Should shocks still be administered during implantable cardioverter-defibrillator insertion?
    Ideker, RE
    Epstein, AE
    Plumb, VJ
    HEART RHYTHM, 2005, 2 (05) : 462 - 463
  • [29] Assessment of Implantable Cardioverter-Defibrillator Used in Heart Failure with Reduced Ejection Fraction as Primary Prevention in an Underserved Population
    Yifan Lu
    Ningxin Wan
    Nidhi Madan
    Ninel Hovnanians
    Juan Carlos Ruiz Diaz
    Panagiota Christia
    Robert Faillace
    Journal of General Internal Medicine, 2018, 33 : 1854 - 1856
  • [30] The subcutaneous implantable cardioverterdefibrillator should be considered for all patients with an implantable cardioverter-defibrillator indication
    Tan, Jian Liang
    Russo, Andrea M.
    HEART RHYTHM O2, 2022, 3 (05): : 589 - 596
12345